The Bisoprolol — A High Selective Beta-Blocker According to Evidence Based Medicine

Rational Pharmacotherapy in Cardiology - Russian Federation
doi 10.20996/1819-6446-2010-6-1-103-107
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Stolichnaya Izdatelskaya Kompaniyaizdat

Related search

Positions of Calcium Channel Blocker Lercanidipine According to Evidence Based Cardiology

Rational Pharmacotherapy in Cardiology
Cardiovascular MedicinePharmacologyCardiology
2010English

Assessment of a Novel Transdermal Selective Β1-Blocker, the Bisoprolol Patch, for Treating Frequent Premature Ventricular Contractions in Patients Without Structural Heart Disease

Journal of Cardiology
Cardiovascular MedicineCardiology
2017English

Assessing the Evidence in Evidence-Based Medicine

Nutrition in Clinical Practice
MedicineNutritionDietetics
2018English

Evidence-Based Medicine

JAMA - Journal of the American Medical Association
Medicine
2006English

Evidence-Based Medicine

JAMA - Journal of the American Medical Association
Medicine
2009English

Effect on Hemodynamics of ACE Inhibitor, Lisinopril, And, .BETA.1-selective .BETA.-blocker, Betaxolol in Essential Hypertension.

Japanese Journal of Clinical Pharmacology and Therapeutics
Pharmacology
1990English

Evidence-Based Medicine

Revista do Hospital das Clínicas
2000English

Mistletoe: From Mythology to Evidence-Based Medicine

Translational Research in Biomedicine
BiochemistryGeneticsMolecular Biology
2015English

Evidence-Based Medicine and Complementary Medicine

Evidence-Based Mental Health
PsychiatryMental Health
1999English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy